Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src
Related Experiment Video
Updated: Oct 24, 2026

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions
Published on: May 28, 2017
J W Wills1, R C Craven, R A Weldon
1Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, Shreveport 71130.
Abstract:
The molecular mechanism by which retroviral Gag proteins are directed to the plasma membrane for the formation of particles (budding) is unknown, but it is widely believed that the MA domain, located at the amino terminus, plays a critical role. Consistent with this idea, we found that small deletions in this segment of the Rous sarcoma virus Gag protein completely blocked particle formation. The mutant proteins appear to have suffered only localized structural damage since they could be rescued (i.e., packaged into particles) when coexpressed with Gag proteins that are competent for particle formation. To our surprise, the effects of the MA deletions could be completely suppressed by fusing as few as seven residues of the myristylated amino terminus of the oncoprotein p60src to the beginning of the mutant Gag proteins. Particles produced by the chimeras were of the same density as the wild type. Two myristylated peptides having sequences distinct from that of p60src were entirely unable to suppress MA deletions, indicating that myristate alone is not a sufficient membrane targeting signal. We hypothesize that the amino terminus of p60src suppresses the effects of MA deletions by diverting the Rous sarcoma virus Gag protein from its normal site of assembly to the Src receptor for particle formation.
Insights
Rous sarcoma virus Gag protein deletions block particle formation. Fusing a specific amino-terminal sequence from p60src rescues this defect, suggesting a novel membrane targeting mechanism for retroviral budding.
Area of Science:
- Molecular Virology
- Cell Biology
- Protein Trafficking
Background:
- The mechanism directing retroviral Gag proteins to the plasma membrane for particle formation (budding) is not fully understood.
- The matrix (MA) domain at the amino terminus of Gag proteins is hypothesized to be critical for this process.
Purpose of the Study:
- To investigate the role of the MA domain in Rous sarcoma virus (RSV) Gag protein localization and particle formation.
- To identify signals that can overcome defects caused by MA domain deletions.
Main Methods:
- Generated Rous sarcoma virus Gag proteins with small deletions in the MA domain.
- Assessed particle formation by expressing mutant and chimeric Gag proteins.
- Investigated the effect of fusing specific peptide sequences, including the myristylated amino terminus of p60src, to mutant Gag proteins.
Main Results:
- Small deletions in the RSV Gag MA domain completely abolished particle formation.
- These defects were rescued by coexpression with wild-type Gag proteins, indicating localized structural damage.
- Fusion of the myristylated amino terminus of p60src, but not other myristylated peptides, suppressed the MA deletion phenotype, restoring particle formation.
Conclusions:
- The MA domain is essential for Rous sarcoma virus Gag protein targeting and particle formation.
- Myristoylation alone is insufficient for membrane targeting; specific protein sequences are required.
- The amino terminus of p60src may divert Gag proteins to a specific receptor, overriding the MA domain's normal function in assembly.
More Related Videos
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Related Concept Videos
Retrovirus Life Cycles
Retroviruses
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly